Two Seas Capital’s PAVmed PAVM Stock Holding History

Two Seas Capital’s Portfolio PAVM Stock Details PAVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.74M	Hold	461,539	–	–	0.05%	46
2026 Q1	$4.68M	Buy	+461,539	New	+$4.37M	0.07%	41

Other funds holding PAVM

First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Two Seas Capital's PAVM Position: Q2 2026 in Review

Two Seas Capital held its PAVmed (PAVM) position steady in Q2 2026 at 461,539 shares worth $2.74M. The position accounts for 0.05% of the portfolio, ranked #46.

Two Seas Capital first reported a position in PAVM in Q1 2026 and has held it in 2 quarters since. The position peaked at $4.68M in Q1 2026. 20 funds tracked by Wall St. Rank hold PAVM as of Q2 2026.

Two Seas Capital held 461,539 shares of PAVmed worth $2.74M as of Q2 2026.
Two Seas Capital left its PAVmed share count unchanged in Q2 2026.
PAVmed made up 0.05% of Two Seas Capital's portfolio in Q2 2026, its #46 holding.
Two Seas Capital first reported a position in PAVmed in Q1 2026 and has held it in 2 quarters since.
Two Seas Capital's PAVmed position peaked at $4.68M in Q1 2026.
20 funds tracked by Wall St. Rank held PAVmed as of Q2 2026.

Based on Two Seas Capital's 13F filing for Q2 2026, filed 12 Aug 2026.